The anticonvulsant action of the carbonic anhydrase inhibitor methazolamide: possible involvement of a noradrenergic mechanism.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001545:Benserazide / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D004983:Ethanolamines / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D002040:Levobunolol / Q000494:pharmacology; D008297:Male; D008704:Methazolamide / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000502:physiology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D013890:Thiourea / Q000031:analogs & derivatives; D014043:Tolazoline / Q000494:pharmacology
D000927:Anticonvulsants; D002257:Carbonic Anhydrase Inhibitors; D004983:Ethanolamines; D013844:Thiazoles; D010643:Phenoxybenzamine; D012701:Serotonin; D010672:Phenytoin; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D012110:Reserpine; D011433:Propranolol; D014043:Tolazoline; D004299:Dopamine beta-Hydroxylase; D002040:Levobunolol; D013890:Thiourea; D007545:Isoproterenol; D011217:Practolol; D008704:Methazolamide; D009638:Norepinephrine; D010646:Phentolamine